Olivier CB - Search Results

1

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study.

Heger LA, Danzer M, Bode C, Hortmann M, Duerschmied D, Olivier CB, Moser M. Heger LA, et al. Among authors: olivier cb. Front Med (Lausanne). 2020 Sep 30;7:414. doi: 10.3389/fmed.2020.00414. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33117822 Free PMC article.

2

Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.

Diehl P, Olivier C, Halscheid C, Helbing T, Bode C, Moser M. Diehl P, et al. Basic Res Cardiol. 2010 May;105(3):379-87. doi: 10.1007/s00395-009-0073-8. Epub 2009 Nov 27. Basic Res Cardiol. 2010. PMID: 19943165 Clinical Trial.

3

Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation.

Diehl P, Halscheid C, Olivier C, Helbing T, Bode C, Moser M. Diehl P, et al. Clin Res Cardiol. 2011 Sep;100(9):765-71. doi: 10.1007/s00392-011-0310-7. Epub 2011 Apr 9. Clin Res Cardiol. 2011. PMID: 21479772

4

Editorial comment: Reduction of oxidative stress: a new indication for acetylsalicylic acid in coronary artery bypass surgery.

Diehl P, Olivier C, Bode C, Moser M. Diehl P, et al. Eur J Cardiothorac Surg. 2013 Jun;43(6):1163-4. doi: 10.1093/ejcts/ezs614. Epub 2012 Dec 6. Eur J Cardiothorac Surg. 2013. PMID: 23220870 No abstract available.

5

Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.

Olivier CB, Diehl P, Schnabel K, Weik P, Zhou Q, Bode C, Moser M. Olivier CB, et al. Thromb Haemost. 2014 Feb;111(2):266-72. doi: 10.1160/TH13-06-0508. Epub 2013 Oct 31. Thromb Haemost. 2014. PMID: 24172891

6

Triple antithrombotic therapy in cardiac patients: more questions than answers.

Moser M, Olivier CB, Bode C. Moser M, et al. Among authors: olivier cb. Eur Heart J. 2014 Jan;35(4):216-23. doi: 10.1093/eurheartj/eht461. Epub 2013 Dec 2. Eur Heart J. 2014. PMID: 24302275 Review.

7

A high ratio of ADP-TRAP induced platelet aggregation is associated more strongly with increased mortality after coronary stent implantation than high conventional ADP induced aggregation alone.

Olivier CB, Schnabel K, Brandt C, Weik P, Olschewski M, Zhou Q, Bode C, Diehl P, Moser M. Olivier CB, et al. Clin Res Cardiol. 2014 Dec;103(12):968-75. doi: 10.1007/s00392-014-0737-8. Epub 2014 Jul 16. Clin Res Cardiol. 2014. PMID: 25027180 Clinical Trial.

8

Thrombin receptor antagonism in antiplatelet therapy.

Olivier C, Diehl P, Bode C, Moser M. Olivier C, et al. Cardiol Ther. 2013 Jun;2(1):57-68. doi: 10.1007/s40119-013-0013-4. Epub 2013 Mar 7. Cardiol Ther. 2013. PMID: 25135289 Free PMC article.

9

[Antiplatelet therapy after acute coronary syndrome. Therapeutic strategies and treatment duration].

Olivier CB, Diehl P, Bode C, Moser M. Olivier CB, et al. Herz. 2014 Nov;39(7):808-13. doi: 10.1007/s00059-014-4162-6. Herz. 2014. PMID: 25359405 Review. German.

10

Role of microparticles in endothelial dysfunction and arterial hypertension.

Helbing T, Olivier C, Bode C, Moser M, Diehl P. Helbing T, et al. World J Cardiol. 2014 Nov 26;6(11):1135-9. doi: 10.4330/wjc.v6.i11.1135. World J Cardiol. 2014. PMID: 25429325 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page